EUVIMEDEUVIMED entdecken
Open Access

Platelet-Associated microRNAs as Markers of Aspirin Response and Pregnancy Outcome in Pregnancies at High-Risk for Preeclampsia

Rupsa C Boelig iD, Antonios Tawk, Tingting Zhan, Walter K Kraft, Steven E McKenzie, James Michael

American Journal of Perinatology · 2026-03 · 43 (04) · 557-560

DOI: 10.1055/a-2677-6668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 26.08.2025. Verfasst von Rupsa C Boelig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal Fetal Medicine, Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Aspirin, Pre-Eclampsia, MicroRNAs, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspirin is recommended in high-risk pregnancies for the prevention of preeclampsia/preterm birth; it is unclear whether aspirin's antiplatelet or anti-inflammatory (or both) effects drive its efficacy, and there are no established markers of therapeutic efficacy for pregnancy-specific outcomes. MicroRNAs (miR) are noncoding posttranscriptional modifiers implicated in preeclampsia/preterm birth and platelet function. We aimed to evaluate whether selected platelet-associated miRs were associated with platelet inhibition following aspirin use and associated with perinatal outcomes. This is a planned secondary analysis of a cohort of high-risk singleton pregnancies taking aspirin. Participants had bloodwork done in the first trimester, preaspirin, 2 to 4 weeks after aspirin initiation (follow-up 1), and at 28 to 32 weeks of gestation (follow-up 2). We selected six platelet-associated miRs (16, 18a, 126, 155, 181a, and 223) that are also associated with preeclampsia and reported quantity as fold-change from baseline (follow-up/baseline). We evaluated with univariate analysis the relationship between miR fold-change at follow-up visits 1 and 2 with Platelet Function Assay-100 epinephrine closure time (PFA-100, Siemens), a measure of aspirin response. We also evaluated the relationship between miR fold-change from baseline at each visit and the outcome of (1) hypertensive disorders of pregnancy (HDP): preeclampsia or gestational hypertension and (2) preterm birth < 37 weeks. Of the original cohort, 57 were included in this secondary analysis. The fold-change in miR-223 and miR-18a significantly decreased with increasing PFA-100 epinephrine closure time. Twelve (21%) pregnancies had HDP, and eight (14%) had preterm birth < 37 weeks. Four preterm births were due to severe preeclampsia, and one was preeclampsia without severe features and spontaneous labor. Fold-change in miRs was not associated with HDP, but increased miR-223 at 28 to 32 weeks was significantly associated with an increased risk of preterm birth (odds ratio: 2.77 [1.21–6.87]; p = 0.04). Selected platelet-associated miRs may be promising markers to assess the therapeutic effect of aspirin in pregnancy and warrant further exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinPre-EclampsiaMicroRNAsPlatelet Aggregation InhibitorsBlood PlateletsHumansFemalePregnancyAdultBiomarkersPregnancy OutcomePremature BirthPregnancy, High-RiskPlatelet Function Tests

Substanzen

AspirinMicroRNAsPlatelet Aggregation InhibitorsBiomarkers

Autor:innen und Institutionen

  • Division of Maternal Fetal Medicine, Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
  • Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
  • Division of Hematology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Division of Biostatistics, Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.

ORCID-Profile: Rupsa C Boelig

Förderung

  • NICHD NIH HHS

Zitieren

APA

Boelig, R. C., Tawk, A., Zhan, T., Kraft, W. K., McKenzie, S. E., & Michael, J. (2026). Platelet-Associated microRNAs as Markers of Aspirin Response and Pregnancy Outcome in Pregnancies at High-Risk for Preeclampsia. American Journal of Perinatology, 43(04), 557-560. https://doi.org/10.1055/a-2677-6668

Vancouver

Boelig RC, Tawk A, Zhan T, Kraft WK, McKenzie SE, Michael J. Platelet-Associated microRNAs as Markers of Aspirin Response and Pregnancy Outcome in Pregnancies at High-Risk for Preeclampsia. American Journal of Perinatology. 2026;43(04):557-560. doi:10.1055/a-2677-6668

BibTeX
@article{Boelig2026,
  author = {Boelig, Rupsa C and Tawk, Antonios and Zhan, Tingting and Kraft, Walter K and McKenzie, Steven E and Michael, James},
  title = {Platelet-Associated microRNAs as Markers of Aspirin Response and Pregnancy Outcome in Pregnancies at High-Risk for Preeclampsia},
  journal = {American Journal of Perinatology},
  year = {2026},
  volume = {43},
  number = {04},
  pages = {557--560},
  doi = {10.1055/a-2677-6668}
}
Kostenlos starten →